Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
about
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureusManagement of community-associated methicillin-resistant Staphylococcus aureus infections in children.Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureusPediatricians' perspectives on the impact of MRSA in primary care: a qualitative study.Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia.National athletic trainers' association position statement: skin diseases.Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United StatesCommunity-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006.Elucidation of bacteria found in car interiors and strategies to reduce the presence of potential pathogens.Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach.Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention.Update on clindamycin in the management of bacterial, fungal and protozoal infections.A sentinel fatal paediatric case of community-associated methicillin-resistant Staphylococcus aureus in CanadaControl of antibiotic-resistant bacteria in the office and clinic.Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians.Antibiotic overuse and resistance in dermatology.Systematic review of duration and choice of systemic antibiotic therapy for acute haematogenous bacterial osteomyelitis in children.Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis.Six-Year Retrospective Review of Hospital Data on Antimicrobial Resistance Profile of Staphylococcus aureus Isolated from Skin Infections from a Single Institution in Greece.The MRSA Epidemic and/as Fluid Biopolitics
P2860
Q24678579-9C92394C-3202-4577-AB97-F63F266279E3Q33264579-82F3B3D6-14FA-448B-9E8A-DE35DBF52C51Q33305151-E73C85F6-06DA-4EF8-BF31-DBF6DCF62E9FQ33430160-39A5646B-CF67-4158-AC06-07E49E72EB27Q33927162-40A695DE-F75C-46E0-B4DE-A96718DA5848Q33984713-752D3600-80AB-4BBE-B7AA-06951A210F02Q34108596-E18A0C8C-D452-4905-B5AD-A1D7D28F7F35Q34603556-7093CFA5-2111-40F6-8A15-8E94B84CC028Q35101792-9EBDA6D0-A607-4B23-A891-A3DA949C4C0DQ35379738-C2DCFD56-E535-40AF-8268-6B72C925CE1AQ35689299-E67EB5E0-2409-487D-8E8B-C01063D2A6FEQ36379346-2F684CA9-383F-4435-AAA7-870EF764EED5Q36563779-A57E9EBF-27E0-4992-9F9D-9C74CE8AF7D2Q36703883-B6E2DB09-0A3E-44C0-9780-E27FCA23ED08Q36967293-7424C384-FF03-4469-9F42-10E9D4F630D9Q37333745-FB9F1CA6-7904-4C1E-80BE-5606E26615F2Q37477929-B8B01950-9E3A-4D2E-B909-23615079EE0BQ37819539-850A6CC3-1E6A-4E51-9950-855655E81A31Q37848082-3DA2BB07-0F35-4A0E-93E5-375AEF04E179Q38010519-F93893B7-A15E-404D-9C1B-559F1912E0CCQ38112778-2E1F1861-DD96-413C-8166-382494740034Q38748268-CDD09A6E-6562-4577-979A-DDC430DA0A36Q47168090-B0340909-6A02-41D4-9E32-37606F92621CQ57984679-E6317839-B4E3-4142-BA64-0BB9A7777242
P2860
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@ast
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@en
type
label
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@ast
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@en
prefLabel
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@ast
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@en
P1476
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.
@en
P2093
Sheldon L Kaplan
P304
P356
10.1097/01.INF.0000164162.00163.9D
P577
2005-05-01T00:00:00Z